Navigation Links
China Focus@Europe 2019 to be Held in November in Hamburg; Early Bird Discount Available
Date:10/4/2019

Representatives with MyBioGate (https://events.mybiogate.com/) announced that China Focus@Europe 2019 will be held November 10 at the Grand Elysée Hamburg Rothenbaumchaussee in Hamburg.

“To better connect Chinese companies and European markets, China Focus comes to Europe again this November,” said Miao Guo, Vice President of Operations and spokesperson for MyBioGate.

Guo went on to highlight that China Focus@Euorpe will bring together investors, pharma leaders, and innovators from China and around the world for an exclusive partnering event designed to inspire, educate and foster cross-border investment and collaboration in leading biopharma innovations.

Guo noted that the event would feature keynote speech, panel discussions, Chinese companies showcase, 1-on-1 meetings, and company presentations (Pitch & Match).

Guo added that Forum Admissions are available at an early bird rate of €845+19% VAT after a discount of €150, and Group discounts are available for 3 or more attendees. Company presentations (Pitch & Match) also has a €500 off for the first 5 registrants. Send inquiry to info (at) mybiogate (dot) com for more details.

“The pharma market in China grew to about Rmb1,558bn (US$226bn) in 2018, at a CAGR of 10% in 2013-18, becoming the 2nd largest pharma market in the world,” Guo highlighted, before adding, “as the youngest member of ICH (International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use), China joined with the least experience but holding the promise to bring domestic clinical trials to world standard and open its market. There will be new revenues for innovative therapeutics and more business development opportunities for global players. The current U.S.-China relationship and CFIUS regulations in the U.S. derived interest from some Chinese investors to the European market.”

Regarding the topics to be discussed at the event, Guo explained that the topics include: NMPA (previously CFDA) regulatory reforms and new opportunities for biotech & pharma; opportunities and barriers for new Chinese players entering the market; new IPO opportunities and the impact on the valuation of biotech companies; European biotech space: how is it unique?; and current and future hot spots in modality and therapeutic area – how can China and Europe join forces?

China Focus@Europe 2019, according to Guo, is designed to provide a meaningful platform to inform, inspire, and foster cross-border partnerships in life science and healthcare.

The event will feature speakers such as Stephen Sunderland, Partner, L.E.K. Consulting; Dong Chen, Senior Director and China head of business development, Jiangsu Hengrui Medicine; Sebastian Gensior, Founder, Sino-European Pharma Forum (SEPF); Managing Director, Global Health Access Solutions; James Huang, Managing Partner, KPCB China, and more to be announced soon.

For more information, please visit: https://events.mybiogate.com/europe/.

About China Focus
China Focus brings together investors, pharma leaders, and innovators from China and around the world for an exclusive partnering event designed to inspire, educate, and foster cross-border investment and collaboration in leading biopharma innovations.

Contact Details:

Feier Chen
Marketing Manager

7707 Fannin Street
Ste. 200
Houston, TX 77054
United States

Phone: (832) 497-2220
Email: feier.chen at mybiogate.com

Source: MyBioGate Inc. (event.mybiogate.com)

Read the full story at https://www.prweb.com/releases/china_focus_europe_2019_to_be_held_in_november_in_hamburg_early_bird_discount_available/prweb16626420.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. China Focus@Biotech Week Boston to be Held in September
2. Proficiency Testing Programme in China Yields Positive Results
3. Greenberg Traurig Hosts Boston Healthcare Drinks and Discussion on China Biopharma Industry
4. Plant diversity in China vital for global food security
5. New parasitoid wasp species found in China
6. Is Chinas 50 percent cesarean section delivery rate too high?
7. Study measures steep coastal costs of Chinas GDP growth
8. Broccoli sprout drink enhances detoxification of air pollutants in clinical trial in China
9. China today: Culprit, victim or last best hope for a global ecological civilisation?
10. A master of disguise: A new stick insect species from China
11. Solar panel manufacturing is greener in Europe than China, study says
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... ... October 10, 2019 , ... ... ultrasound, invites attendees of the American Society of Anesthesiologists 2019 Annual Meeting to ... on October 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare ...
(Date:10/8/2019)... (PRWEB) , ... October 07, 2019 , ... The future ... to the genetic level, resulting in people living longer, healthier lives. But it will ... on earth. , Leroy E. Hood, MD, PhD, Chief Strategy Officer and Co-Founder of ...
(Date:10/3/2019)... ... October 02, 2019 , ... Personalized Stem Cells, ... patient in an FDA approved clinical trial for stem cell treatment of knee ... formation of the company as a subsidiary of VetStem Biopharma. , PSC CEO, Michael ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... , ... October 09, 2019 , ... ... Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for ... 2019 in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative ...
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has ... October 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. ... several Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Madhumita Suresh and Leslie Maurer presented company executives with a set of recommendations ... (MBS) graduates will offer insights from their TMP to a wider audience of ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company ... technology. Like the company’s precursor patent, approved in the U.S. in 2017, the ... stem cells. Asymmetrex now markets the technology in the U.S. as the AlphaSTEM ...
Breaking Biology Technology: